Orphenadrine citrate 25 mg / aspirin 385 mg / caffeine 30 mg Oral Tablet
RxNorm 994528
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 994528 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: orphenadrine citrate 25 mg / aspirin 385 mg / caffeine 30 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Aspirin 385 mg / caffeine 30 mg / orphenadrine citrate 25 mg Oral Tablet
(Atom ID: 12344341)
SYPrescribable
Synonym (SY):
ASA 385 mg / Caffeine 30 mg / Orphenadrine Citrate 25 mg Oral Tablet
(Atom ID: 3852990)
PTPrescribable
Designated preferred name (PT):
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet
(Atom ID: 9248878)
PSNPrescribable
Prescribable Name (PSN):
Orphenadrine citrate 25 mg / aspirin 385 mg / caffeine 30 mg Oral Tablet
(Atom ID: 6358646)
FNPrescribable